Protagonist Therapeutics Inc
NASDAQ:PTGX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Protagonist Therapeutics Inc
NASDAQ:PTGX
|
US |
|
Otis Worldwide Corp
NYSE:OTIS
|
US |
|
Bureau Veritas SA
PAR:BVI
|
FR |
|
Leggett & Platt Inc
NYSE:LEG
|
US |
|
B
|
Bank CIMB Niaga Tbk PT
IDX:BNGA
|
ID |
|
Selective Insurance Group Inc
NASDAQ:SIGI
|
US |
|
T
|
Textron Inc
SWB:TXT
|
US |
|
B
|
Bank Mandiri (Persero) Tbk PT
F:PQ9
|
ID |
|
Pliant Therapeutics Inc
NASDAQ:PLRX
|
US |
|
E
|
Energy SpA
F:S2I
|
IT |
|
E
|
Elica SpA
F:7L4
|
IT |
|
Ubiquiti Inc
NYSE:UI
|
US |
|
P
|
Petroleo Brasileiro SA Petrobras
F:PJXC
|
BR |
|
Orexo AB
STO:ORX
|
SE |
|
T
|
TAG Immobilien AG
OTC:TAGYY
|
DE |
|
Grenevia SA
F:8MF
|
PL |
|
Z
|
Zevra Therapeutics Inc
F:1GDA
|
US |
|
ESCO Technologies Inc
NYSE:ESE
|
US |
|
Old Second Bancorp Inc
F:OSB
|
US |
|
T
|
Teladoc Health Inc
SWB:4LL
|
US |
Bankruptcy Probability
Protagonist Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Protagonist Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Protagonist Therapeutics Inc
NASDAQ:PTGX
|
9.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Protagonist Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Protagonist Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
